Ocular MECP2 Protein Expression in Patients With and Without Rett Syndrome

Pediatric Neurology

Volumn 43, Issue 1, 2010, Pages 35-40

  Jain, Deepali ^a   Singh, Kamaljeet ^a   Chirumamilla, Sankar ^a   Bibat, Genila M ^a,b   Blue, Mary E ^a,b   Naidu, SakkuBai R ^a,b   Eberhart, Charles G ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b KENNEDY KRIEGER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METHYL CPG BINDING PROTEIN 2; NUCLEAR PROTEIN;

ADOLESCENT; ADULT; AGED; ANIMAL TISSUE; ARTICLE; BRAIN; CASE REPORT; CLINICAL FEATURE; CONTROLLED STUDY; EYE; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFANT; MEDICAL HISTORY; MISSENSE MUTATION; MOUSE; NERVE CELL; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RETINA AMACRINE CELL; RETT SYNDROME; VISION; VISUAL SYSTEM;

ADOLESCENT; ADULT; AGED; ANIMALS; BRAIN; EYE; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INFANT; INFANT, NEWBORN; METHYL-CPG-BINDING PROTEIN 2; MICE; MICE, KNOCKOUT; MIDDLE AGED; NEURONS; RETT SYNDROME;

EID: 77953010061     PISSN: 08878994     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pediatrneurol.2010.02.018     Document Type: Article

References (36)

1. Shahbazian M.D., Antalffy B., Armstrong D.L., et al. Insight into Rett syndrome: MECP2 levels display tissue- and cell-specific differences and correlate with neuronal maturation. Hum Mol Genet 11 (2002) 115-124
2. Trevathan E., and Naidu S. The clinical recognition and differential diagnosis of Rett syndrome. J Child Neurol (1988) 3 Suppl:S6-16
3. Amir R.E., Van den Veyver I.B., Wan M., Tran C.Q., Francke U., and Zoghbi H.Y. Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat Genet 23 (1999) 185-188
4. International Rett Syndrome Foundation (IRSF). RettBASE: IRSF MECP2 Variation Database [Internet]. Available at: http://MECP2.chw.edu.au. Accessed June, 2009.
5. Chahrour M., Jung S.Y., Shaw C., et al. MECP2, a key contributor to neurological disease, activates and represses transcription. Science 320 (2008) 1224-1229
6. Meehan R.R., Lewis J.D., and Bird A.P. Characterization of MECP2, a vertebrate DNA binding protein with affinity for methylated DNA. Nucleic Acids Res 20 (1992) 5085-5092
7. Balmer D., Goldstine J., Rao Y.M., and LaSalle J.M. Elevated methyl-CpG-binding protein 2 expression is acquired during postnatal human brain development and is correlated with alternative polyadenylation. J Mol Med 81 (2003) 61-68
8. Armstrong D.D., Deguchi K., and Antallfy B. Survey of MECP2 in the Rett syndrome and the non-Rett syndrome brain. J Child Neurol 18 (2003) 683-687
9. Cassel S., Revel M.O., Kelche C., and Zwiller J. Expression of the methyl-CpG-binding protein MECP2 in rat brain: an ontogenetic study. Neurobiol Dis 15 (2004) 206-211
10. Maezawa I., Swanberg S., Harvey D., LaSalle J.M., and Jin L.W. Rett syndrome astrocytes are abnormal and spread MECP2 deficiency through gap junctions. J Neurosci 29 (2009) 5051-5061
11. Ballas N., Lioy D.T., Grunseich C., and Mandel G. Non-cell autonomous influence of MECP2-deficient glia on neuronal dendritic morphology. Nat Neurosci 12 (2009) 311-317
12. Saunders K.J., McCulloch D.L., and Kerr A.M. Visual function in Rett syndrome. Dev Med Child Neurol 37 (1995) 496-504
13. Kalmanchey R. Evoked potentials in the Rett syndrome. Brain Dev 12 (1990) 73-76
14. Glaze D.G. Neurophysiology of Rett syndrome. J Child Neurol 20 (2005) 740-746
15. Carter J.C., Lanham D.C., Pham D., Bibat G., Naidu S., and Kaufmann W.E. Selective cerebral volume reduction in Rett syndrome: a multiple-approach MR imaging study. AJNR Am J Neuroradiol 29 (2008) 436-441
16. Armstrong D.D. Rett syndrome: neuropathology review 2000. Brain Dev 23 Suppl. 1 (2001) S72-S76
17. Hagberg B., and Witt-Engerström I. Rett syndrome: a suggested staging system for describing impairment profile with increasing age towards adolescence. Am J Med Genet Suppl 1 (1986) 47-59
18. Renieri A., Meloni I., Longo I., et al. Rett syndrome: the complex nature of a monogenic disease. J Mol Med 81 (2003) 346-354
19. Naidu S., Bibat G., Kratz L., et al. Clinical variability in Rett syndrome. J Child Neurol 18 (2003) 662-668
20. Hoffbuhr K.C., Moses L.M., Jerdonek M.A., Naidu S., and Hoffman E.P. Associations between MECP2 mutations, X-chromosome inactivation, and phenotype. Ment Retard Dev Disabil Res Rev 8 (2002) 99-105
21. Schollen E., Smeets E., Deflem E., Fryns J.P., and Matthijs G. Gross rearrangements in the MECP2 gene in three patients with Rett syndrome: implications for routine diagnosis of Rett syndrome. Hum Mutat 22 (2003) 116-120
22. Laccone F., Jünemann I., Whatley S., et al. Large deletions of the MECP2 gene detected by gene dosage analysis in patients with Rett syndrome [Erratum in: Hum Mutat 2004;23:395]. Hum Mutat 23 (2004) 234-244
23. Mnatzakanian G.N., Lohi H., Munteanu I., et al. A previously unidentified MECP2 open reading frame defines a new protein isoform relevant to Rett syndrome [Erratum in: Nat Genet 2004;36:540]. Nat Genet 36 (2004) 339-341
24. Hoffbuhr K., Devaney J.M., LaFleur B., et al. MECP2 mutations in children with and without the phenotype of Rett syndrome. Neurology 56 (2001) 1486-1495
25. Ballestar E., Yusufzai T.M., and Wolffe A.P. Effects of Rett syndrome mutations of the methyl-CpG binding domain of the transcriptional repressor MECP2 on selectivity for association with methylated DNA. Biochemistry 39 (2000) 7100-7106
26. Armstrong D.D. The neuropathology of Rett syndrome. Brain Dev 14 (1992) Suppl:S89-98
27. Naidu S. Rett syndrome: a disorder affecting early brain growth. Ann Neurol 42 (1997) 3-10
28. Armstrong D.D., Dunn J.K., Schultz R.J., Herbert D.A., Glaze D.G., and Motil K.J. Organ growth in Rett syndrome: a postmortem examination analysis. Pediatr Neurol 20 (1999) 125-129
29. Armstrong D., Dunn J.K., Antalffy B., and Trivedi R. Selective dendritic alterations in the cortex of Rett syndrome. J Neuropathol Exp Neurol 54 (1995) 195-201
30. Armstrong D.D., Dunn K., and Antalffy B. Decreased dendritic branching in frontal, motor and limbic cortex in Rett syndrome compared with trisomy 21. J Neuropathol Exp Neurol 57 (1998) 1013-1017
31. Mahmood A., Bibat G., Zhan A.L., et al. White matter impairment in Rett syndrome: diffusion tensor imaging study with clinical correlations. AJNR Am J Neuroradiol 31 (2010) 295-299
32. Cohen D.R., Matarazzo V., Palmer A.M., et al. Expression of MECP2 in olfactory receptor neurons is developmentally regulated and occurs before synaptogenesis. Mol Cell Neurosci 22 (2003) 417-429
33. Armstrong D.D. Neuropathology of Rett syndrome. Ment Retard Dev Disabil Res Rev 8 (2002) 72-76
34. Akbarian S., Chen R.Z., Gribnau J., et al. Expression pattern of the Rett syndrome gene MeCP2 in primate prefrontal cortex. Neurobiol Dis 8 (2001) 784-791
35. Johnston M.V., Blue M.E., and Naidu S. Rett syndrome and neuronal development. J Child Neurol 20 (2005) 759-763
36. Baccus S.A., Olveczky B.P., Manu M., and Meister M. A retinal circuit that computes object motion. J Neurosci 28 (2008) 6807-6817